Fulcrum Therapeutics, Inc. (FULC)
3.725
-0.02
(-0.67%)
USD |
NASDAQ |
Nov 18, 16:00
3.725
0.00 (0.00%)
After-Hours: 18:52
Fulcrum Therapeutics Total Liabilities (Quarterly) : 8.784M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 8.784M |
| June 30, 2026 | 13.26M |
| March 31, 2026 | 13.47M |
| December 31, 2025 | 17.28M |
| September 30, 2025 | 16.49M |
| June 30, 2025 | 14.46M |
| March 31, 2025 | 14.16M |
| December 31, 2024 | 17.68M |
| September 30, 2024 | 21.72M |
| June 30, 2024 | 20.47M |
| March 31, 2024 | 19.00M |
| December 31, 2023 | 22.50M |
| September 30, 2023 | 23.42M |
| June 30, 2023 | 24.90M |
| March 31, 2023 | 24.86M |
| December 31, 2022 | 27.74M |
| Date | Value |
|---|---|
| September 30, 2022 | 26.39M |
| June 30, 2022 | 34.48M |
| March 31, 2022 | 31.09M |
| December 31, 2021 | 23.46M |
| September 30, 2021 | 24.94M |
| June 30, 2021 | 26.99M |
| March 31, 2021 | 28.72M |
| December 31, 2020 | 34.40M |
| September 30, 2020 | 37.23M |
| June 30, 2020 | 22.73M |
| March 31, 2020 | 24.22M |
| December 31, 2019 | 23.29M |
| September 30, 2019 | 13.83M |
| June 30, 2019 | 176.83M |
| March 31, 2019 | 175.28M |
| December 31, 2018 | 149.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.098M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 93.70M |
| Definium Therapeutics, Inc. | 106.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 310.81M |
| Shareholders Equity (Quarterly) | 302.03M |
| Debt to Equity Ratio | 0.0226 |
| Current Ratio | 36.19 |
| Net Debt Paydown Yield | 0.05% |